InMed Pharmaceuticals (INM) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free INM Stock Alerts $0.23 -0.02 (-8.00%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInMed (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMDtheglobeandmail.com - April 17 at 12:42 PMInMed Pharmaceuticals (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extensiontheglobeandmail.com - March 23 at 9:38 PMInMed Pharmaceuticals Welcomes New CFO Neeta Jagpalmarkets.businessinsider.com - February 10 at 9:11 AMInMed Pharmaceuticals Announces New CFO Appointmentmsn.com - February 10 at 9:11 AMInMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officerfinance.yahoo.com - February 9 at 9:43 AMInMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet Needbenzinga.com - January 25 at 9:27 PMInMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ETfinance.yahoo.com - January 18 at 6:37 PMInMed Pharmaceuticals: InMed Announces Results of 2023 Annual General Meetingfinanznachrichten.de - December 20 at 7:49 AMInMed Announces Results of 2023 Annual General Meetingfinance.yahoo.com - December 19 at 8:08 PMInMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Updatefinance.yahoo.com - November 14 at 8:42 AMInMed Pharmaceuticals files to sell 12.57M shares for holdersmsn.com - November 8 at 6:33 PMInMed Pharmaceuticals Inc INMmorningstar.com - November 8 at 1:32 AMInMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023finance.yahoo.com - November 2 at 9:37 AMInMed Pharmaceuticals Announces the Closing of $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - October 27 at 12:17 AMWhy Is InMed Pharmaceuticals (INM) Stock Down 25% Today?investorplace.com - October 25 at 11:02 AMInMed Pharmaceuticals to raise $5.2M via private placementmsn.com - October 24 at 6:06 PMInMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq Rulesfinance.yahoo.com - October 24 at 6:06 PMDow Surges 250 Points; US Manufacturing PMI Tops Expectationsbenzinga.com - October 24 at 1:06 PMWhy InMed Pharmaceuticals Stock Is Soaring Tuesdaybenzinga.com - October 24 at 1:06 PMmarketbeat.com - October 24 at 10:11 AMmarketbeat.com - October 24 at 9:56 AMmarketbeat.com - October 24 at 9:43 AMmarketbeat.com - October 24 at 9:35 AMInMed Pharmaceuticals (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate Updatetheglobeandmail.com - October 3 at 12:51 AMInMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Updatefinance.yahoo.com - September 29 at 3:45 PMThis Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness Sectorbenzinga.com - September 15 at 1:34 PMInMed to Present at H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 9:38 AMINM - InMed Pharmaceuticals Inc.au.finance.yahoo.com - July 22 at 4:46 PMInMed to Participate in Fireside Chat with Water Tower Research on July 25, 2023 at 2pm ETfinance.yahoo.com - July 21 at 12:27 PMWhy Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionmsn.com - June 22 at 3:44 PMWhy Are InMed Pharmaceuticals Stock Trading Lower Todayfinance.yahoo.com - June 22 at 3:44 PMInMed Pharmaceuticals Inc. Announces Results from a Phase 2 Clinical Trial in Epidermolysis Bullosafinance.yahoo.com - June 22 at 9:51 AMStudy Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatmentmsn.com - June 1 at 7:21 PMInMed Pharmaceuticals: InMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience Meetingfinanznachrichten.de - June 1 at 9:20 AMInMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience Meetingfinance.yahoo.com - June 1 at 9:20 AMInMed to Participate in Upcoming Virtual Investor Eventsfinance.yahoo.com - May 24 at 7:22 PMInMed to Participate in Fireside Chat with Water Tower Research on May 23, 2023 at 1pm ETfinance.yahoo.com - May 18 at 5:44 PMInMed Pharmaceuticals GAAP EPS of -$0.60, revenue of $1.03Mseekingalpha.com - May 15 at 8:23 PMInMed Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 15 at 3:19 PMBiosynthesis of Cannabinoids Market Size: Growth Dynamics from 2023 to 2030marketwatch.com - April 21 at 2:49 AM2023-2029 Bed Head Panel Market Size and Industrial Analysis with Key Developments | Latest Report by Absolute Reportsmarketwatch.com - March 30 at 2:11 AMInMed Announces Conclusion of Patient Enrollment in Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosafinance.yahoo.com - March 28 at 8:17 AMSpasticity Treatment Market Growth and Forecast till 2029marketwatch.com - March 20 at 10:39 PMRare Cannabinoids Could Help Treat Atopic Dermatitis, Psoriasis, Pruritus And Acne: New Studymsn.com - March 13 at 4:31 PMPresenting on the Emerging Growth Conference on March 8 Register Nowfinance.yahoo.com - March 7 at 7:58 AMInMed to Participate in Upcoming Investor Eventsfinance.yahoo.com - March 6 at 9:58 PMBiosynthesis of Canabinoids Market International Business Analysis, Development Outlook and Regional Strategies 2028marketwatch.com - February 24 at 2:24 AMThis Company's Rare Cannabinoids May Hold Promise In The Treatment Of Neurodegenerative Diseases Like Alzheimer'sbenzinga.com - January 11 at 9:40 AMBiosynthesis of Cannabinoids Market Size and Share Likely to Grow with CAGR Status and Industry Revenue Forecast by 2023-2029marketwatch.com - January 2 at 7:35 AMInMed Announces Results of 2022 Annual General Meetingfinance.yahoo.com - December 15 at 7:55 PM Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. INM Media Mentions By Week INM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INM News Sentiment▼-1.000.32▲Average Medical News Sentiment INM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INM Articles This Week▼10▲INM Articles Average Week Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CMRA News DRMA News PBLA News QLGN News LSDI News GLMD News GRI News BPTH News CMND News HSTO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INM) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsThey say it’s ‘unstoppable’ – How I made 43,509% Investing Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
